Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Immunoglobulin Light-chain Amyloidosis × Pharmacogenomic Testing × Clear all

Sponsor

Conditions

Breast Neoplasms 4 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Lymphoma, Mantle-Cell 2 Lymphoma 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Unspecified Adult Solid Tumor, Protocol Specific 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Squamous Cell Carcinoma of Head and Neck 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms, Plasma Cell 1 Neoplasm Metastasis 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Melanoma 1 Malignant Tumor of Ill-defined Site 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Myeloid, Acute 1

Interventions

Dexamethasone 15 Melphalan 13 Bortezomib 10 Calcium Dobesilate 7 Filgrastim 6 Granulocyte Colony-Stimulating Factor 5 birtamimab 4 Cyclophosphamide 4 dexamethasone acetate 3 Thalidomide 3 Peripheral Blood Stem Cell Transplantation 3 Lenalidomide 3 fludarabine phosphate 2 daratumumab 2 Whole-Body Irradiation 2 Mycophenolic Acid 2 Doxycycline 2 Darbepoetin alfa 2 Cyclosporine 2 Blood Component Removal 2 pomalidomide 1 pegfilgrastim 1 isatuximab 1 ferrous sulfate 1 ferric gluconate 1 dexamethasone 21-phosphate 1 carfilzomib 1 Therapeutics 1 Surveys and Questionnaires 1 Sucrose 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡